Cord Blood

Study findings on cord blood are outlined in reports from S.Y. Huh and colleagues

Published in Stem Cell Week, November 3rd, 2008

"Animal data show that decreased activity of placental 11-beta-hydroxysteroid dehydrogenase type 2 (11 beta-HSD2), which potently inactivates glucocorticoids (e. g. cortisol) to inert forms (cortisone), allows increased access of maternal glucocorticoids to the fetus and 'programs' hypertension. Data in humans are limited," scientists in the United States report.

"We examined in humans the association between venous umbilical cord blood glucocorticoids, a potential marker for placental 11 beta-HSD2 enzyme activity, and blood pressure at age 3 years. Among 286 newborns in Project Viva, a prospective pre-birth cohort study based in eastern Massachusetts, we measured...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Stem Cell Week

Source: Stem Cell Week (2008-11-03)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry